Clinical Neuroscience of HIV Program

Overview

This program supports clinical neuroscience research across the lifespan in key populations exposed to, placed at risk for, or living with HIV. Specifically, the program encourages studies that address neurocognitive, behavioral, and psychiatric consequences of HIV, as well as factors that may modify the risk for, or the manifestation of, these consequences. The program also encourages studies that utilize cognitive, neuroscientific, and basic behavioral research-based approaches to optimize HIV prevention and treatment. Studies that utilize approaches aligned with the NIMH Research Domain Criteria (RDoC) are encouraged, as are those that utilize socioecological process models to identify the impacts of lifespan, structural, and individual-level factors on HIV outcomes are encouraged.

Areas of emphasis

• Neurobehavioral consequences of HIV/AIDS and its treatments, its heterogeneity, and longitudinal course.
• Basic behavioral and neuroscientific research addressing possible approaches for interventions to improve HIV prevention and care.
• Neurobehavioral sequelae of exposure to HIV or other infections during fetal development or perinatally, as well as early identification of individuals who were exposed and may benefit from interventions.
• Neurobehavioral interventions to improve cognitive and behavioral function in HIV-associated neurocognitive disorders.

Basic neuroscience aspects of NeuroAIDS and its therapeutic approaches are covered by the HIV Neuropathogenesis, Genetics, and Therapeutics Branch.

Contact

Anaïs Stenson
Program Officer
Clinical Neuroscience of HIV Program
HIV Data Science, Developmental, Social, and Translational Research Branch
Division of AIDS Research, National Institute of Mental Health (NIMH)
stensonaf@nih.gov
(240) 926-7572